hg_133837.1

Basic information about the TSS

---

TSS ID: hg_133837.1 Species: human Chr: chr12		Start: 122526555 End: 122526614 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: BC008684 Distance: -309 GeneID: 65117 HGNC/MGI_ID: HGNC:30559 UniProt_ID:

Gene_name: arginine and serine rich coiled-coil 2 Gene_symbol: RSRC2 Gene_synonyms: FLJ11021 Gene_source: HGNC:30559

TATA-Box annotation

---

Distance to TSS:	351
Nearest PromoterID:	NM_023012
Entrez ID:	65117
Nearest Unigene:	Hs.432996
Nearest Refseq:	NM_023012
Nearest Ensembl:	ENSG00000111011
Gene Name:	arginine and serine rich coiled-coil 2
Gene Alias:	-
Gene Description:	arginine and serine rich coiled-coil 2
Gene Type:	protein-coding
CpG%:	0.03
GC%:	0.502488
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	56(TTTTTTAGGGCC,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RSRC2 p2@RSRC2 p3@RSRC2 p4@RSRC2 p5@RSRC2
Sample		p1@RSRC2	p2@RSRC2	p3@RSRC2	p4@RSRC2	p5@RSRC2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	153.31	3.70	4.09	1.36	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	140.81	2.83	4.05	2.43	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	160.88	5.02	7.14	0.58	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	106.66	2.70	1.66	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	112.03	3.82	2.70	0.90	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	124.62	2.91	2.33	0.78	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	142.93	7.41	4.79	2.18	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	127.41	5.57	3.88	1.45	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	95.96	5.34	2.14	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	478.77	15.07	9.27	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	391.30	16.17	8.89	3.23	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	458.59	17.89	6.10	1.63	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	33.37	2.10	0.64	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	33.68	2.71	0.90	0.30	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	38.20	1.32	0.22	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.16	2.01	0.50	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	31.23	1.31	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.31	1.69	1.27	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.92	1.07	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	39.72	3.01	0.75	0.60	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	33.15	2.14	0.53	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.84	1.55	0.17	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.83	2.07	0.90	0.13	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.49	2.91	0.24	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	33.28	1.29	0.26	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	39.25	1.90	0.63	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	23.63	1.10	1.10	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	34.18	2.12	0.94	0.94	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.00	1.29	0.32	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	35.11	1.27	1.09	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	25.75	0.63	0.42	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.96	0.98	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.68	1.27	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	34.97	1.48	0.16	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	32.72	1.68	0.00	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.68	1.72	0.38	0.77	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.45	1.02	0.82	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.78	1.01	0.20	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.65	2.16	1.35	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.57	1.20	0.48	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.76	0.71	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	32.35	1.61	0.44	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	37.75	2.11	0.42	0.84	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.62	1.22	0.35	0.70	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.59	1.81	0.60	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	44.44	1.16	0.47	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.43	1.68	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.07	2.38	0.89	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.15	2.63	0.72	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	49.54	2.63	0.40	0.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.99	2.25	1.02	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	48.03	2.89	0.22	0.89	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	867.52	13.99	83.95	69.96	83.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	30.87	1.77	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	29.82	3.31	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	163.59	12.58	7.55	3.36	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	70.72	1.84	0.00	1.38	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.06	1.30	0.97	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.62	1.61	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	64.75	2.83	0.94	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.79	3.53	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.80	2.80	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	97.93	3.18	3.18	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	49.61	2.04	1.36	0.00	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	51.01	2.60	0.65	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.95	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1212.29	32.33	48.49	32.33	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	837.13	31.59	15.79	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.74	0.49	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	28.76	0.99	0.00	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.55	2.81	0.00	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	45.04	2.32	1.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	36.50	0.62	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	27.82	1.22	0.31	0.61	0.00
Adipocyte - breast, donor1	11376-118A8	35.95	1.43	0.79	0.63	0.00
Adipocyte - breast, donor2	11327-117E4	27.91	0.80	1.28	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	45.04	1.40	0.13	0.38	0.64
Adipocyte - omental, donor2	11474-119C7	30.65	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	29.47	1.34	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	30.62	1.28	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	16.49	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	10.84	0.45	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	14.77	0.17	0.87	0.70	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	55.93	2.35	0.20	0.39	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	40.41	2.57	0.51	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	34.85	2.23	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	61.13	1.76	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	77.05	2.25	0.48	0.56	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	46.15	2.26	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	28.26	2.67	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	40.06	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	26.62	1.66	0.00	1.25	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	34.41	2.01	0.50	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	28.80	1.64	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	2.44	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	9.94	0.88	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	6.81	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.93	1.08	0.18	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	10.68	0.21	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	35.01	1.83	0.69	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	25.96	1.22	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	28.75	0.90	0.90	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	0.43	1.74	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	2.14	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	2.09	1.20	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	39.20	1.26	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	1.32	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.19	1.62	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	26.21	0.00	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	1.78	1.19	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	27.87	1.51	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	23.95	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	31.14	0.99	0.16	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.00	0.90	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	1.07	0.00	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	20.97	1.32	0.57	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.72	1.60	1.60	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	24.39	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	22.06	1.33	0.83	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	9.61	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	24.70	1.20	0.69	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	21.36	0.00	0.97	3.40	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	21.25	0.76	0.76	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	0.00	0.00	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.31	1.07	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.03	1.03	0.26	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	23.46	0.47	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.83	0.64	1.61	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.81	0.00	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.99	1.51	0.00	0.90	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	1.19	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	23.90	0.00	2.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	26.74	1.78	1.78	0.76	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	1.29	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.92	0.85	1.06	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.05	0.58	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	0.94	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	19.66	0.68	0.51	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	2.11	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	22.94	0.43	0.43	0.86	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	28.88	1.20	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	25.51	1.46	1.46	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	25.98	0.23	1.15	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	27.71	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.09	1.03	1.03	1.24	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.95	0.61	0.92	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	30.59	0.00	0.48	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	28.38	0.44	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	1.53	4.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.16	1.11	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	21.71	0.79	0.26	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	1.09	1.09	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	25.79	0.86	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	14.04	0.86	0.00	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	10.70	0.63	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	84.01	4.88	0.35	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	61.80	3.40	2.59	0.97	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	73.54	4.77	1.19	0.60	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	132.58	7.45	3.44	1.83	2.06
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	142.82	8.52	3.13	3.01	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	144.86	9.67	3.30	2.62	1.37
Basophils, donor1	12241-129G9	82.38	4.45	0.00	0.00	0.00
Basophils, donor2	12242-129H1	262.66	12.27	0.36	0.00	0.72
Basophils, donor3	12243-129H2	119.80	5.14	0.73	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	0.00	0.22	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	4.11	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	20.71	1.26	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	9.36	0.62	0.21	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	19.80	1.38	0.46	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	35.09	2.52	1.44	1.26	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	107.69	4.43	1.75	0.82	1.03
Burkitt's lymphoma cell line:RAJI	10476-106I8	106.20	8.62	1.63	0.93	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	87.94	8.31	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	186.15	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	137.51	9.58	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	165.74	8.35	3.90	2.23	1.48
CD14+ Monocytes, donor3	11381-118B4	153.24	8.78	1.98	2.20	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	53.78	3.68	0.00	0.28	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	62.93	3.03	0.00	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	80.87	3.62	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	91.07	4.91	1.30	1.73	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	96.86	4.83	0.91	1.81	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	111.10	4.50	1.42	1.90	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	94.58	3.01	1.51	1.51	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	115.37	4.14	1.38	1.38	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	147.52	4.71	2.23	1.98	1.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	70.49	2.35	1.17	0.39	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	80.30	3.03	1.25	1.25	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	156.26	3.70	1.31	1.74	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	108.17	3.51	0.70	1.64	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	161.05	6.86	3.17	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	142.00	7.77	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	83.15	2.97	2.97	1.19	1.78
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	95.58	2.79	1.00	1.80	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	155.11	4.16	0.62	1.46	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	80.30	1.83	2.29	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	110.84	4.30	0.68	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	111.30	3.06	0.87	1.75	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	80.70	3.77	1.08	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	92.46	5.41	3.49	1.05	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	95.53	4.21	2.10	2.52	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	83.59	1.47	3.31	2.57	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	108.15	4.58	2.82	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	113.63	3.95	0.88	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	85.27	4.88	4.01	1.57	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	109.27	3.35	3.72	2.23	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	182.57	6.04	1.72	1.08	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	93.36	2.87	1.64	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	131.20	3.25	0.70	0.70	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	127.83	3.71	0.23	1.62	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	104.62	5.45	0.44	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	88.47	3.93	0.46	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	65.85	3.47	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	92.65	5.61	0.93	0.62	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	80.16	6.11	0.52	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	160.31	13.82	0.67	0.89	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	78.34	1.53	0.51	0.00	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	89.14	2.63	1.32	0.66	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	86.74	4.00	0.42	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	8.13	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	120.00	8.81	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	99.42	5.18	1.04	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	164.18	10.13	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	149.56	8.04	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	108.80	4.21	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	107.46	7.84	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	123.92	6.59	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	253.15	34.52	1.64	6.58	0.82
CD19+ B Cells, donor2	11624-122B4	243.02	17.41	4.35	3.63	2.90
CD19+ B Cells, donor3	11705-123B4	253.42	27.77	3.53	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	355.97	12.12	3.23	1.21	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	201.34	7.59	0.40	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	101.41	10.04	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	248.88	12.92	0.56	1.12	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	87.18	5.64	0.00	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	91.32	7.22	0.00	0.23	0.68
CD4+ T Cells, donor1	11225-116C1	583.07	28.21	2.86	2.14	1.43
CD4+ T Cells, donor2	11306-117C1	332.51	23.27	9.19	4.29	2.45
CD4+ T Cells, donor3	11382-118B5	321.46	20.13	6.71	3.66	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	101.07	5.62	0.00	1.28	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	97.03	6.29	0.45	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	91.70	5.17	0.29	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	236.10	14.22	2.37	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	210.70	14.75	1.40	2.11	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	151.63	16.48	0.00	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	82.08	4.62	0.58	0.43	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.79	5.25	1.19	0.85	0.68
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	77.38	6.13	2.58	0.81	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	186.49	8.07	2.69	1.79	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	147.09	10.13	1.75	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	222.19	10.56	3.96	2.20	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	104.99	7.59	0.84	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	68.15	8.10	1.04	1.45	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	55.80	4.34	1.00	0.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	183.01	12.51	1.63	2.45	1.36
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	190.80	11.25	1.07	1.61	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	148.84	10.76	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	96.98	6.49	0.93	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	74.73	5.42	0.43	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	89.52	5.04	0.21	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	163.82	12.64	0.00	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	147.74	9.53	0.43	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	261.05	16.56	2.18	1.31	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	111.84	10.89	0.49	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	121.86	3.69	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	128.42	6.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	227.36	8.58	0.55	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	225.02	13.25	0.25	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	147.84	10.78	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	152.92	7.52	0.72	0.72	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	108.03	5.54	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	381.74	18.99	2.95	1.96	0.00
CD8+ T Cells, donor2	11307-117C2	299.97	10.89	7.51	3.75	4.51
CD8+ T Cells, donor3	11383-118B6	362.32	24.74	4.04	4.29	3.28
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	47.03	2.06	0.46	0.46	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	44.57	1.92	0.48	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	47.06	3.01	1.92	1.37	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	61.54	1.50	1.80	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.56	1.92	0.72	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	46.84	2.27	0.68	0.45	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	61.93	2.17	0.43	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	57.12	1.32	1.05	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	55.81	1.64	0.94	0.70	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	67.32	0.91	2.42	0.60	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	62.17	2.03	2.03	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	57.82	1.87	0.80	1.33	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	82.73	2.19	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	103.38	2.28	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	115.61	2.24	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.57	1.44	0.72	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	46.32	1.15	0.86	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.30	2.59	0.24	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	65.92	0.63	0.95	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	59.36	2.77	1.23	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	59.31	0.64	0.96	0.32	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	74.96	2.68	3.06	0.76	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	61.48	1.58	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	76.40	0.00	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	300.31	6.42	7.23	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	333.63	6.29	5.60	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	363.64	9.02	8.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	0.00	0.00	3.66	0.00
Cardiac Myocyte, donor2	11605-120I3	25.69	2.47	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	26.94	1.26	0.11	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	62.40	2.43	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	24.17	0.36	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	28.44	1.02	0.91	0.34	0.34
Chondrocyte - re diff, donor2	11339-117F7	86.84	0.90	0.90	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	40.04	0.81	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	72.07	2.87	0.34	0.46	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	42.33	3.21	1.28	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	44.07	2.83	1.24	0.27	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.20	2.48	0.46	0.73	0.37
Corneal Epithelial Cells, donor1	11526-119I5	5.49	0.44	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	9.97	0.77	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	45.07	1.98	0.66	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.70	1.26	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	34.12	1.08	0.32	0.43	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	154.42	9.22	0.34	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	163.87	11.10	0.00	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	211.00	18.39	0.00	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	19.18	0.50	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	15.26	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.01	0.00	0.28	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	18.87	1.97	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.27	0.29	0.29	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	27.06	1.18	0.24	0.71	0.47
Endothelial Cells - Artery, donor3	11413-118E9	23.84	0.70	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.47	0.44	0.44	0.00	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	46.86	1.83	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	67.37	0.28	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	19.61	0.59	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.45	0.28	0.57	0.28	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	73.62	0.40	0.40	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	14.68	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	79.14	2.73	0.87	0.75	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.27	3.48	0.87	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	54.96	2.69	0.24	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	23.89	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	21.98	1.10	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	106.73	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	209.58	13.20	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	146.24	17.83	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	7.57	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	39.82	1.64	1.23	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	12.59	0.77	0.55	0.00	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.88	1.08	0.54	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.32	1.94	0.73	0.24	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.11	3.28	0.14	0.41	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	20.88	1.05	0.63	0.63	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	73.78	1.84	0.79	1.05	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	44.85	3.32	1.33	0.66	1.00
Fibroblast - Cardiac, donor1	11268-116G8	19.05	1.81	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	12.13	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	17.03	0.95	0.63	0.32	0.00
Fibroblast - Cardiac, donor4	11452-119A3	68.20	3.94	0.00	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	44.80	1.90	0.13	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	46.39	1.97	0.45	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.39	0.54	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	24.16	2.59	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	1.46	5.86	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	38.06	1.38	0.46	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	46.47	2.37	0.51	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	23.01	0.70	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	14.15	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	23.94	0.60	1.21	0.60	0.36
Fibroblast - Dermal, donor4	11450-119A1	79.92	4.86	1.02	0.45	0.23
Fibroblast - Dermal, donor5	11454-119A5	68.21	3.14	0.35	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	76.83	2.76	0.32	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	49.35	2.71	0.42	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	60.26	2.88	0.52	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	49.68	2.64	1.84	0.40	0.66
Fibroblast - Gingival, donor3	11394-118C8	64.88	2.61	0.39	0.48	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.55	1.76	1.23	0.70	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	54.25	3.90	1.40	0.94	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	46.38	2.84	0.95	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.53	1.41	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	53.96	3.36	0.88	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	69.54	3.00	0.95	1.23	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	72.18	3.62	0.77	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	64.42	4.99	0.44	0.59	0.15
Fibroblast - Lung, donor1	11270-116H1	13.59	1.36	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	47.75	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	25.54	3.17	0.42	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.52	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	25.58	0.41	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	53.92	1.94	0.97	0.19	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	69.93	3.94	1.67	1.06	1.37
Fibroblast - Periodontal Ligament, donor3	11395-118C9	89.35	4.59	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	38.93	2.29	0.76	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.32	1.08	0.00	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	25.28	1.62	0.46	0.35	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.74	1.11	0.66	0.33	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	16.46	0.81	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	18.04	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	18.58	0.40	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	124.43	3.18	0.99	1.59	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	47.60	1.24	0.53	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	47.89	0.99	0.79	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	68.90	3.31	0.00	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	64.66	1.51	0.32	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	87.31	3.80	1.52	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	36.26	1.31	0.82	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	117.90	4.61	0.80	0.40	1.20
Fibroblast - skin normal, donor2	11561-120D4	65.00	1.41	0.10	0.70	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	105.48	3.93	0.91	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	49.87	1.74	0.33	0.33	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	79.49	2.39	1.37	0.00	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	76.20	1.64	0.99	1.64	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	64.98	1.28	0.75	0.53	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	30.70	1.52	1.01	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	38.26	1.88	1.25	0.63	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1019.35	44.32	44.32	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	87.15	7.84	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	37.79	0.69	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	52.57	1.30	0.26	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	51.61	1.79	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.86	3.83	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	58.06	3.83	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	185.71	13.12	3.14	3.14	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	159.39	10.48	5.24	1.65	1.38
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	113.02	13.24	1.83	0.68	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	109.17	12.09	3.76	2.38	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	132.17	11.90	3.17	1.85	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	85.12	13.05	2.28	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	156.55	11.94	3.98	3.98	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	124.79	6.22	2.12	2.12	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	83.49	2.83	1.23	1.23	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	64.47	5.10	2.69	0.81	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	70.00	1.36	1.73	0.74	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	70.60	3.05	1.52	0.69	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	61.80	4.47	1.63	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.29	2.05	0.68	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	58.05	4.11	1.25	0.75	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	77.38	5.03	1.09	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.19	2.07	2.95	0.89	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	84.41	3.66	2.07	0.95	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	52.50	3.13	0.67	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	50.41	2.42	1.41	0.60	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	95.85	3.39	2.37	2.37	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	88.76	4.08	0.98	0.27	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	103.02	4.47	0.94	0.62	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	113.40	3.42	0.34	0.85	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	81.33	2.88	2.21	1.55	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	84.86	3.91	0.92	0.33	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	91.06	3.68	0.61	1.02	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	65.19	3.71	1.24	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	79.55	2.65	1.96	0.81	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.37	3.00	0.83	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	47.39	2.20	1.32	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	76.13	4.06	0.86	1.23	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	62.57	4.05	1.46	1.13	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	58.37	0.64	1.92	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.27	2.08	1.14	0.76	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.71	1.58	1.58	0.32	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.74	2.43	1.22	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	69.31	1.46	1.36	1.46	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.20	1.76	1.54	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	57.51	1.40	2.52	1.12	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	59.07	2.50	0.65	0.46	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	45.46	1.60	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.17	1.84	1.22	0.15	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	57.77	0.78	1.17	1.17	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	46.08	1.63	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	48.30	1.66	2.03	1.29	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	43.86	3.51	1.32	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	131.90	5.95	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	38.91	1.32	1.19	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.98	0.40	1.41	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	156.05	5.34	0.25	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	173.78	7.17	2.59	0.80	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	115.40	4.47	3.54	2.00	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	143.21	6.14	2.66	1.84	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	61.02	1.25	0.63	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	47.19	3.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	99.16	3.23	2.77	0.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	81.67	4.95	2.47	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	92.45	5.03	3.09	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	80.22	9.63	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	71.29	3.48	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	83.97	2.60	2.93	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	106.66	5.77	3.71	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	3.33	19.99	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	94.24	5.87	1.12	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.79	2.61	1.96	0.65	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	99.82	1.68	11.74	3.36	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	100.83	4.77	2.54	1.91	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	70.31	4.08	1.02	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	8.35	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	101.37	3.44	0.57	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	68.96	2.66	2.96	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	96.57	3.39	1.69	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	99.82	6.21	4.14	2.49	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	88.60	4.83	2.76	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	105.37	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	62.27	4.23	1.54	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	83.77	3.26	0.98	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	63.54	4.01	1.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	90.15	3.08	0.77	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	92.77	6.16	1.37	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	111.82	0.00	12.42	4.97	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	116.08	7.55	3.30	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.13	5.43	3.02	0.60	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	127.68	4.58	1.02	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	117.66	4.79	2.39	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	118.90	7.89	1.97	2.47	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	146.37	9.44	7.08	2.36	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	100.94	2.92	2.33	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	138.25	6.58	3.07	1.32	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	101.72	3.39	7.63	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	53.72	1.19	0.60	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	72.79	5.34	0.97	2.43	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	20.79	1.25	1.25	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	6.75	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.84	1.59	1.59	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	14.62	0.42	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	50.25	2.90	1.28	1.16	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	53.68	3.04	1.35	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	48.91	2.96	1.59	1.37	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	45.47	2.40	0.87	0.87	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	46.64	2.58	1.72	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.15	2.37	0.22	1.08	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	46.20	2.37	2.62	1.25	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	53.87	1.89	1.03	0.86	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	55.42	3.52	0.64	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	7.79	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	34.37	2.64	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	12.70	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	10.17	1.45	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	21.51	1.40	0.70	0.70	0.35
Hepatocyte, donor1	11523-119I2	41.16	2.42	1.21	2.42	1.21
Hepatocyte, donor2	11603-120I1	64.64	5.39	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	73.62	3.07	1.84	2.45	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	98.56	7.83	3.92	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	101.02	2.80	0.87	1.22	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	41.02	2.20	1.23	0.41	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	70.05	9.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	71.99	4.15	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	15.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	64.97	9.75	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	68.36	3.33	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	79.41	14.56	1.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	113.08	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	83.81	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	122.82	2.52	1.26	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	9.28	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	113.06	10.34	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	106.26	4.83	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	238.96	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	114.90	8.15	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	28.97	3.78	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	201.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	111.71	5.63	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	52.63	4.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	44.84	4.25	0.94	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	77.09	8.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	176.91	44.23	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	74.25	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	77.50	6.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	79.07	4.46	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	60.15	9.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	221.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	82.83	4.28	2.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	73.00	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	47.22	2.47	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	125.73	3.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	44.50	2.78	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	29.18	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	2.62	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	27.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	41.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	30.94	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	36.02	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	37.74	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	30.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	29.61	1.06	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	30.35	1.14	0.49	0.16	0.24
Keratinocyte - epidermal, donor2	11349-117G8	9.37	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.20	3.12	1.89	0.76	0.38
Keratinocyte - oral, donor1	11251-116E9	53.35	2.04	1.14	0.23	0.34
Keratocytes, donor1	11527-119I6	22.35	1.38	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	17.78	1.19	1.19	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	237.37	15.39	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	23.73	2.16	1.08	3.24	0.00
Lens Epithelial Cells, donor2	11609-120I7	59.40	2.65	0.35	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	40.16	1.11	0.00	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.48	0.24	0.24	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.86	0.00	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	31.32	1.10	1.10	0.79	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.21	1.08	0.54	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	8.82	0.63	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.27	0.22	0.54	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.27	2.05	0.41	1.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.34	1.26	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	0.42	0.99	0.56	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	33.22	0.79	0.40	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.01	0.19	0.58	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.04	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.27	0.72	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	11.40	0.55	0.69	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	0.62	1.23	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.04	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.99	0.55	0.18	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.34	0.66	0.66	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.30	0.59	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.72	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.86	0.97	1.45	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.58	0.81	0.54	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.14	0.61	0.76	0.15	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	0.52	0.00	1.56	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	33.08	1.68	1.88	0.63	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.78	0.75	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	1.38	1.38	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.70	0.94	0.38	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.75	0.21	0.53	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.85	0.00	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	9.42	0.12	0.74	0.62	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.39	0.74	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	21.00	0.49	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.17	0.96	0.55	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	29.59	0.64	1.93	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	37.43	0.91	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.33	0.70	0.84	0.70	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	19.91	0.36	0.00	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.18	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.25	0.16	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	13.25	0.00	0.36	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.95	0.65	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.53	0.71	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.18	0.50	0.25	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.81	0.51	0.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	12.83	0.00	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	32.22	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	31.17	2.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.93	1.69	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	2.81	0.70	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	20.55	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.19	3.09	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	14.27	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.77	1.13	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	34.03	1.74	1.16	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.21	2.70	0.90	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	25.61	3.12	0.27	0.14	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.60	2.05	1.03	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	27.88	1.76	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.99	3.33	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	30.05	2.55	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	25.08	3.47	0.00	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	39.11	3.40	0.76	1.70	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	20.25	2.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	33.43	1.63	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.07	2.50	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	35.03	2.24	0.28	0.00	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	17.52	0.00	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	35.42	2.61	0.87	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	21.82	4.19	1.20	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	29.32	1.66	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	32.87	1.41	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.24	2.58	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	24.94	1.15	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.74	0.00	2.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	27.90	0.82	0.00	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	23.05	3.62	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	29.44	2.87	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	30.62	2.24	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	34.56	3.34	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	26.28	0.86	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	35.32	3.66	0.33	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	24.13	3.62	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	29.15	4.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	2.06	0.34	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	27.37	0.00	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	20.87	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	31.11	3.70	0.74	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	15.12	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	23.27	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	35.21	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	29.80	2.91	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	2.30	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	39.96	0.99	0.00	0.00	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	19.76	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	31.17	2.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	26.59	4.06	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	34.29	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.88	3.91	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	26.39	0.66	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	21.28	2.08	0.00	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	35.01	2.63	0.00	0.88	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	22.92	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	27.38	2.65	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.79	3.09	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	26.84	2.03	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	25.47	1.44	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	24.65	1.59	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.13	3.04	0.00	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	1.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	24.32	2.28	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	18.59	2.58	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	16.33	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	21.55	2.85	0.32	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.92	3.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	23.56	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	27.77	1.54	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.00	2.27	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	20.80	2.91	0.83	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	18.79	2.35	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.70	2.92	0.00	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	25.09	0.46	0.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	17.40	2.01	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	27.80	3.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	26.27	3.23	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	24.78	2.75	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	28.49	2.28	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	28.38	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	31.19	3.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	21.83	2.23	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	27.56	1.30	0.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	23.87	3.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	35.55	2.96	0.00	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	33.03	2.39	0.00	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	26.87	2.10	0.52	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.68	1.06	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	86.99	2.54	1.74	0.79	0.48
Mallassez-derived cells, donor3	11930-125I4	65.32	1.95	0.56	0.83	0.14
Mammary Epithelial Cell, donor1	11273-116H4	102.83	4.48	2.69	1.30	1.10
Mammary Epithelial Cell, donor2	11350-117G9	68.62	3.76	4.05	2.61	0.87
Mammary Epithelial Cell, donor3	11422-118F9	11.47	0.25	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	1023.68	42.71	5.42	2.71	1.36
Mast cell, donor1	11563-120D6	103.38	5.41	0.97	0.54	0.76
Mast cell, donor2	11565-120D8	181.87	20.51	0.89	1.19	0.00
Mast cell, donor3	11566-120D9	179.20	18.24	0.45	0.45	0.23
Mast cell, donor4	11567-120E1	173.57	15.42	0.53	0.00	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	112.22	4.77	2.00	1.11	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	90.47	3.50	0.00	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	71.13	3.79	0.69	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	80.50	3.68	1.34	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	45.57	1.29	0.30	0.30	0.70
Melanocyte - dark, donor2	11582-120F7	25.61	1.38	1.04	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	75.41	2.46	1.09	0.43	0.14
Melanocyte - light, donor1	11274-116H5	8.46	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	8.19	2.05	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	9.54	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	43.21	1.98	0.73	0.42	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	34.69	0.54	1.88	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	45.54	1.07	0.27	0.27	0.00
Meningeal Cells, donor1	11493-119E8	29.77	1.36	0.00	0.00	0.00
Meningeal Cells, donor2	11573-120E7	23.33	1.32	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	66.59	1.87	0.98	0.24	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.49	2.85	0.29	0.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.99	0.70	0.20	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	2.62	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	18.66	3.59	1.44	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	32.61	0.42	0.64	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.69	0.50	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.97	0.88	0.22	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.07	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.21	0.61	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	40.44	1.66	0.42	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	1.12	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	41.18	1.05	1.32	0.00	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	10.98	0.00	0.30	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.73	1.28	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.55	2.13	0.00	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.33	0.94	0.31	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	26.12	2.18	0.73	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	29.43	1.06	0.00	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	21.02	0.00	0.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	31.29	1.01	1.08	0.72	1.30
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	58.06	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	35.22	1.97	0.25	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	32.98	3.83	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	23.56	1.86	0.31	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.74	0.83	0.62	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	26.78	2.00	0.25	0.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	23.74	2.33	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.39	1.22	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	21.78	0.79	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	17.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	10.62	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	27.74	2.66	0.76	1.14	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	6.58	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.25	0.64	1.27	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.39	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	24.09	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.05	1.43	0.48	0.48	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	18.80	3.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	36.84	1.84	0.23	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	37.02	2.10	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.56	2.04	0.41	0.82	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	25.32	1.29	0.43	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.57	2.67	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.41	1.53	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	36.50	2.53	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.70	3.81	1.36	0.27	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.58	1.18	0.29	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	2.18	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	20.66	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.42	2.40	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	32.91	5.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	16.52	2.50	0.50	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	57.08	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	28.46	3.94	1.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	28.69	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	43.55	3.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	44.13	1.74	0.99	0.99	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	53.04	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	27.01	0.68	0.34	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	28.01	2.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	40.13	4.97	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	34.51	2.52	0.56	0.56	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	2.49	0.42	0.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	39.04	3.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	25.64	2.11	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.80	2.50	0.00	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	34.17	2.77	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	36.42	2.28	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	46.84	3.04	0.28	0.69	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	32.39	1.04	0.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	39.89	1.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	23.50	2.54	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.96	2.40	0.53	1.07	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	33.23	1.80	0.00	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.51	2.83	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.02	0.96	0.32	0.32	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	39.36	0.22	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	37.16	3.79	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	41.20	2.27	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	36.62	2.46	0.49	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.24	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.64	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.72	1.15	0.29	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	58.11	5.36	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.20	2.08	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	27.60	1.97	1.64	0.99	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	7.36	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.40	1.19	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	40.05	0.93	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.43	2.25	2.25	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.84	2.66	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	32.12	1.58	0.57	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	1.47	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	24.55	1.83	0.00	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	35.78	0.00	3.11	3.11	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	34.20	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	24.46	0.84	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	185.22	2.72	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	38.15	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	48.59	2.43	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	64.95	4.53	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	725.19	11.42	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	809.09	19.57	6.52	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	171.09	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	263.53	12.55	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	39.21	1.08	0.43	0.43	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	49.13	4.70	1.05	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.12	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	85.94	6.08	0.57	1.14	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	215.44	15.96	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	1.36	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	281.16	18.38	7.35	1.84	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	19.25	0.42	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	23.94	2.09	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	26.75	0.81	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	46.88	3.15	0.63	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	801.70	33.40	22.27	11.13	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.86	1.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.17	1.62	0.54	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	21.76	0.91	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	19.11	2.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	44.83	2.92	0.91	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	25.46	1.59	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	108.63	7.55	1.31	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.08	1.14	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	65.79	3.88	0.53	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	21.80	2.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.31	3.22	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	21.85	0.96	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	90.36	4.48	0.69	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	490.52	27.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	51.91	3.34	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.36	0.85	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	32.75	3.32	0.71	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	25.33	1.72	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1074.30	27.08	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	27.66	1.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	33.36	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	1.98	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	30.65	1.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.27	0.65	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	66.49	2.26	1.36	0.45	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	14.63	0.66	0.00	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	25.79	1.98	0.50	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	18.38	2.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	43.55	2.72	0.30	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	53.05	1.11	0.66	1.33	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	495.62	15.33	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.95	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	12.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.55	1.82	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	100.89	9.07	0.00	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	485.56	10.12	15.17	0.00	10.12
Myoblast, donor1	11241-116D8	32.67	1.61	0.12	0.25	0.25
Myoblast, donor2	11322-117D8	39.51	2.49	1.34	0.96	0.77
Myoblast, donor3	11398-118D3	51.96	2.19	0.34	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	62.31	2.33	1.17	1.46	0.58
Natural Killer Cells, donor1	11230-116C6	324.74	17.84	3.08	2.46	0.92
Natural Killer Cells, donor2	11311-117C6	258.13	10.86	9.05	3.32	3.62
Natural Killer Cells, donor3	11387-118C1	268.72	15.46	5.34	2.76	2.39
Neural stem cells, donor1	11275-116H6	216.68	7.26	3.63	0.36	0.73
Neural stem cells, donor2	11352-117H2	315.81	26.96	3.85	3.85	0.00
Neurons, donor1	11494-119E9	100.14	6.83	1.14	3.41	0.00
Neurons, donor2	11574-120E8	83.00	3.74	1.32	0.22	0.22
Neurons, donor3	11655-122E8	162.79	13.15	2.47	0.00	0.00
Neutrophils, donor1	11233-116C9	107.65	13.92	1.86	1.86	0.00
Neutrophils, donor2	11314-117C9	78.27	11.60	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	174.70	21.38	1.22	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	41.91	3.56	0.59	0.47	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	19.86	0.33	0.98	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	19.45	0.60	0.40	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	38.96	1.79	0.96	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	49.50	2.32	2.03	1.01	0.14
Olfactory epithelial cells, donor3	11935-125I9	46.42	2.16	1.48	0.68	0.34
Olfactory epithelial cells, donor4	11936-126A1	50.26	2.05	1.95	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	66.80	2.41	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.93	0.21	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	1.14	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	1.24	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	13.68	0.20	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	54.78	4.92	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	21.68	0.89	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	42.96	2.19	1.35	0.67	0.25
Pericytes, donor1	11491-119E6	8.90	0.45	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	11.54	1.58	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	8.75	0.61	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	47.13	2.26	0.45	0.00	0.11
Perineurial Cells, donor2	11579-120F4	46.19	2.30	0.28	0.37	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	232.04	21.36	1.27	1.27	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	169.93	13.96	2.20	1.22	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	168.76	10.74	0.91	0.91	0.00
Placental Epithelial Cells, donor1	11278-116H9	46.16	0.96	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	22.18	1.11	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	17.28	1.57	0.39	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.25	0.00	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	35.83	1.69	0.75	0.19	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	78.06	2.09	0.52	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	30.62	0.68	0.45	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	38.68	0.85	0.32	0.21	0.11
Preadipocyte - omental, donor2	11329-117E6	54.56	0.87	0.87	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	45.41	1.15	1.15	1.00	0.57
Preadipocyte - perirenal, donor1	11469-119C2	11.81	0.00	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	7.99	0.61	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	55.25	2.66	1.95	1.24	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	27.93	1.02	0.68	0.85	0.34
Preadipocyte - visceral, donor1	11280-116I2	64.92	2.98	0.56	0.09	0.28
Preadipocyte - visceral, donor2	11357-117H7	53.84	3.68	0.46	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	45.24	2.30	0.63	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	78.44	3.47	2.41	0.30	1.21
Prostate Epithelial Cells, donor2	11331-117E8	25.46	0.54	0.00	0.81	0.27
Prostate Epithelial Cells, donor3	11404-118D9	38.76	1.29	1.78	0.86	0.80
Prostate Stromal Cells, donor1	11254-116F3	35.88	0.80	0.11	0.11	0.11
Prostate Stromal Cells, donor2	11332-117E9	41.96	1.97	2.33	1.43	1.08
Prostate Stromal Cells, donor3	11405-118E1	27.63	1.88	0.52	0.31	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.23	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	51.08	1.87	1.04	0.42	0.21
Renal Epithelial Cells, donor1	11517-119H5	10.65	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	12.09	1.42	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	68.07	1.91	1.38	0.32	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.07	0.54	0.13	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	1.11	2.44	0.67	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	12.10	0.66	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.02	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.83	0.28	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.76	1.34	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	13.88	1.16	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	39.15	2.59	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	17.91	0.28	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	0.00	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	37.64	1.76	1.00	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	139.65	6.41	1.34	0.94	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	91.13	4.47	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	206.39	7.71	9.36	2.20	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	272.05	11.60	1.16	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	117.41	3.64	1.04	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	54.12	2.98	2.09	1.09	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	84.55	3.57	1.00	0.33	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	101.10	3.47	2.73	2.36	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	61.65	4.31	1.86	1.75	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	91.30	6.01	1.16	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.36	3.01	0.96	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	62.17	2.57	2.42	1.21	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	61.46	2.51	0.72	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	56.09	2.30	1.72	2.01	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	58.16	2.36	0.97	1.29	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	73.02	4.87	0.89	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	52.57	2.68	0.38	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.44	3.17	0.93	0.93	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	122.70	3.57	2.44	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	62.37	2.79	0.53	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	65.22	2.34	2.63	1.17	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	81.16	3.44	2.48	1.34	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	58.84	3.20	1.07	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	54.38	1.96	1.68	1.96	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	70.75	3.25	4.27	2.22	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	51.42	3.10	0.55	0.91	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	51.38	2.58	1.10	1.35	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	60.71	3.90	2.15	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	73.36	2.59	0.47	1.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.97	3.57	1.39	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	63.84	3.74	2.34	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	69.67	2.07	0.62	1.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	58.40	1.77	2.43	1.99	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	69.56	4.80	1.46	0.84	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	74.29	3.36	1.35	1.35	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	81.06	3.24	0.68	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	87.53	6.36	2.70	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	82.19	1.55	2.06	2.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	63.92	3.29	1.10	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	99.81	3.12	4.10	1.81	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	60.67	2.73	1.02	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	60.51	2.66	2.07	0.74	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	87.43	3.47	1.33	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	59.87	1.66	1.11	0.69	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	50.00	3.33	1.43	0.95	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	112.46	4.03	2.22	1.81	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	55.09	1.98	0.66	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	78.96	3.49	3.14	2.45	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	74.34	3.02	2.42	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	57.77	1.59	0.49	0.61	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	185.14	8.01	1.02	0.44	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	66.93	2.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.35	0.90	0.30	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.94	2.26	1.13	0.90	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	94.06	3.29	3.00	2.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	67.07	2.36	0.71	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.26	2.35	0.43	0.43	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.94	4.81	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	7.52	0.38	0.19	0.19	0.00
Schwann Cells, donor2	11578-120F3	13.61	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.91	1.75	1.53	1.10	0.22
Sebocyte, donor1	11220-116B5	27.94	1.10	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	22.98	0.00	0.46	0.46	0.00
Sebocyte, donor3	11378-118B1	10.10	0.62	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	23.19	0.00	0.00	3.31	0.00
Sertoli Cells, donor2	11333-117F1	39.54	2.82	5.65	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	51.20	2.29	0.35	0.09	0.26
Skeletal Muscle Cells, donor2	11358-117H8	6.51	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	22.57	3.34	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	44.77	2.51	0.31	0.47	0.00
Skeletal Muscle Cells, donor5	11455-119A6	44.00	2.38	0.45	0.45	0.00
Skeletal Muscle Cells, donor6	11459-119B1	52.33	2.77	0.77	0.62	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	55.69	4.03	0.38	0.88	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.25	2.85	0.71	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	48.32	2.48	1.19	0.89	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	43.39	1.35	0.34	0.17	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	19.54	2.90	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	11.42	1.10	0.28	0.00	0.14
Skin - palm, donor1	10286-104F7	139.68	42.98	5.37	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	14.56	1.01	0.58	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	198.75	10.63	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	18.95	1.82	0.52	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	44.62	1.11	0.97	0.56	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	42.34	1.55	0.70	0.56	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	196.86	9.30	1.06	1.06	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	37.55	1.12	1.35	0.22	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	24.07	0.93	0.00	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	50.47	2.22	0.67	0.44	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	10.58	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.56	0.88	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	11.42	0.39	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	10.82	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	1.00	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.65	0.40	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.14	1.55	1.11	0.66	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.26	0.90	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.86	1.63	0.65	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.23	1.77	0.30	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.06	1.00	0.00	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.39	0.00	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.79	0.91	1.52	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	12.12	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	0.00	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.94	1.33	0.00	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	25.61	1.94	0.65	0.86	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.23	2.10	0.52	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	11.91	0.46	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	15.54	1.20	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	55.21	2.20	0.94	0.24	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	35.33	2.21	0.70	0.30	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.95	0.91	0.68	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.85	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	89.54	4.24	0.79	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	53.93	2.40	0.53	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.69	0.88	1.25	0.75	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.50	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	25.03	0.90	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.00	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	29.72	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	1.40	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.17	1.01	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.98	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	5.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	67.23	3.17	0.08	0.25	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	28.03	1.40	0.47	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.79	0.29	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.81	0.25	0.25	0.25	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	15.04	0.94	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	56.46	2.93	0.84	0.28	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.15	1.26	0.08	0.08	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	8.56	0.49	0.00	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	49.27	1.33	0.44	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	39.79	1.76	0.88	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	41.40	1.55	1.17	0.58	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.39	1.32	0.79	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	55.05	1.86	0.37	2.23	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	46.35	1.80	1.80	2.16	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	14.76	1.42	0.28	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	51.99	2.76	1.58	1.97	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	37.58	2.29	1.78	0.00	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	32.74	3.59	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	24.66	1.67	0.42	0.00	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	26.13	2.75	0.00	0.46	0.92
Synoviocyte, donor1	11291-117A4	39.89	1.35	0.84	0.34	0.67
Synoviocyte, donor2	11368-117I9	32.02	1.17	1.34	0.67	0.67
Synoviocyte, donor3	11440-118H9	41.78	1.56	1.12	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	16.44	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	28.02	0.69	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	33.40	1.29	0.22	0.07	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	3.44	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	143.32	6.27	1.35	0.25	0.37
Urethra, donor2	10319-105A4	239.19	32.37	5.40	0.00	1.80
Urothelial Cells, donor1	11520-119H8	6.91	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	5.61	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	6.19	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	46.81	1.56	0.45	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	120.12	15.13	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	144.39	10.01	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.77	6.16	1.37	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	106.74	10.33	1.03	1.03	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	81.34	8.13	0.58	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	131.20	6.25	1.04	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	126.66	5.51	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	50.21	2.74	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	69.21	3.95	1.36	0.86	0.86
Wilms' tumor cell line:HFWT	10597-108E3	80.08	4.40	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	123.46	8.66	3.35	1.12	1.40
achilles tendon, donor2	10292-104G4	123.99	4.13	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	122.89	9.43	6.37	2.04	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	170.18	13.00	2.32	1.39	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	171.53	11.63	2.37	0.71	1.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	120.00	8.44	5.71	1.36	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	84.61	5.34	5.62	1.69	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	84.80	5.92	0.85	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	80.85	4.90	0.82	3.27	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	77.99	1.76	3.53	0.00	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	56.76	3.68	2.45	1.63	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	90.09	3.88	2.33	0.00	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	50.05	3.50	2.39	2.02	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	15.60	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	83.19	7.90	3.02	1.86	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	137.22	10.10	6.99	3.37	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	105.21	7.31	8.77	3.80	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	77.15	4.65	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	60.04	4.11	1.23	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	28.24	2.15	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	83.21	5.12	3.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	84.32	3.64	0.91	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	97.00	2.17	1.20	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	67.04	4.45	3.12	0.45	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	103.40	6.67	0.67	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	302.89	42.74	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	90.78	4.14	1.13	1.13	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	104.24	10.03	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	228.68	20.62	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	76.30	3.30	0.94	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	84.54	3.88	0.78	0.47	0.62
adipose, donor1	10184-103D4	430.42	22.87	9.38	6.45	1.76
adipose, donor2	10185-103D5	58.80	5.27	2.03	0.41	0.81
adipose, donor3	10186-103D6	83.32	8.99	1.63	1.91	0.54
adipose, donor4	10187-103D7	120.48	12.13	8.67	3.47	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	66.92	4.10	0.79	0.95	0.00
adrenal gland, adult, pool1	10081-102A9	58.20	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	66.70	4.54	1.73	0.53	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	94.68	3.57	1.43	0.71	1.07
amniotic membrane cells, donor1	12235-129G3	91.35	4.64	0.23	1.16	0.23
amniotic membrane cells, donor2	12236-129G4	54.10	3.72	0.68	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	76.01	5.01	0.88	1.47	0.29
amygdala - adult, donor10196	10167-103B5	225.30	8.30	9.49	4.74	0.00
amygdala, adult, donor10252	10151-102I7	159.17	9.73	5.27	2.43	1.62
amygdala, newborn, donor10223	10360-105E9	98.77	8.39	2.90	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	71.94	2.93	1.53	0.64	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.80	1.99	1.54	1.54	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	138.29	7.01	0.33	1.67	1.34
aorta, adult, pool1	10052-101G7	54.92	6.08	0.59	0.39	0.59
appendix, adult	10189-103D9	128.08	9.31	2.33	1.94	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	109.37	4.13	2.75	2.41	1.38
artery, adult	10190-103E1	63.86	10.87	1.36	2.72	0.00
astrocytoma cell line:TM-31	10425-106D2	88.80	2.32	1.59	0.72	0.58
b cell line:RPMI1788	10427-106D4	142.60	6.99	3.87	1.19	1.19
basal cell carcinoma cell line:TE 354.T	10702-109G9	37.73	0.55	0.83	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	78.79	2.28	1.19	0.40	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	68.29	2.18	0.67	0.33	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.13	3.36	1.12	0.00	1.12
bladder, adult, pool1	10011-101C2	113.86	6.08	1.20	0.87	0.00
blood, adult, pool1	10053-101G8	46.51	4.43	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	104.47	1.71	0.86	0.86	0.00
bone marrow, adult	10192-103E3	94.48	7.42	8.77	2.02	0.67
brain, adult, donor1	10084-102B3	14.35	3.08	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	96.99	4.68	2.34	1.00	0.67
brain, fetal, pool1	10085-102B4	48.09	13.36	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	131.82	11.23	1.32	0.99	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	153.53	7.11	0.62	0.50	0.62
breast, adult, donor1	10080-102A8	74.50	4.42	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	61.49	5.08	2.29	1.65	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	83.49	4.95	2.78	1.24	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	200.75	10.36	2.53	2.07	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	59.31	3.63	1.69	1.21	1.45
carcinoid cell line:NCI-H1770	10703-109H1	78.99	6.58	1.88	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	111.68	4.81	0.55	0.77	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	109.33	6.65	2.85	2.85	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	100.35	5.86	3.46	2.40	0.53
caudate nucleus - adult, donor10196	10177-103C6	246.38	10.36	8.06	2.30	1.15
caudate nucleus, adult, donor10252	10164-103B2	130.18	4.52	3.35	2.01	1.34
caudate nucleus, adult, donor10258	10379-105H1	78.71	3.82	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	111.70	5.13	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	690.45	14.57	2.91	2.91	2.91
cerebellum, adult, donor10252	10166-103B4	309.80	7.05	10.46	3.20	1.71
cerebellum, adult, pool1	10083-102B2	88.65	4.83	4.48	1.72	1.38
cerebellum, newborn, donor10223	10357-105E6	297.24	16.61	4.15	0.83	0.00
cerebral meninges, adult	10188-103D8	122.04	7.56	1.01	0.00	0.50
cerebrospinal fluid, donor2	10294-104G6	93.55	2.92	2.19	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	66.57	1.29	1.01	0.29	0.14
cervical cancer cell line:ME-180	10553-107I4	55.18	2.82	0.83	0.66	0.50
cervix, adult, pool1	10013-101C4	116.01	6.09	1.36	0.63	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.01	0.70	0.00	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	73.15	5.23	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	106.38	5.59	2.24	0.25	0.62
choriocarcinoma cell line:SCH	10785-110H2	76.02	2.09	2.46	2.34	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	47.44	2.85	0.24	0.47	0.24
chorionic membrane cells, donor1	12238-129G6	84.34	2.28	1.71	1.42	0.57
chorionic membrane cells, donor2	12239-129G7	52.90	1.79	0.30	0.20	0.30
chorionic membrane cells, donor3	12240-129G8	85.17	6.04	4.40	3.85	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	47.46	3.03	4.04	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	59.74	3.46	0.96	0.77	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	73.92	6.55	0.84	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	153.31	7.70	2.57	0.77	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	144.89	6.05	2.42	1.94	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	156.17	6.72	2.04	1.22	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	117.19	3.24	1.77	1.18	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	143.87	7.82	1.82	0.78	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	55.32	2.74	2.29	0.91	0.23
clear cell carcinoma cell line:TEN	10636-108I6	163.79	3.47	1.56	2.43	1.04
colon carcinoma cell line:CACO-2	10513-107D9	81.82	3.84	0.73	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	213.99	9.12	1.90	2.66	0.38
colon, adult, donor1	10082-102B1	44.03	2.38	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	92.71	5.05	0.94	0.47	0.00
colon, fetal, donor1	10070-101I7	92.70	8.03	1.85	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	59.59	36.67	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	503.55	11.47	4.67	2.12	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	151.08	3.92	0.75	0.30	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	143.27	6.49	2.12	1.13	1.13
corpus callosum, adult, pool1	10042-101F6	111.78	6.30	0.88	0.22	0.22
cruciate ligament, donor2	10295-104G7	166.15	13.78	1.62	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	84.27	9.63	1.61	0.80	0.80
diencephalon, adult	10193-103E4	85.68	4.32	3.36	2.40	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	138.00	10.56	8.73	6.43	2.76
ductal cell carcinoma cell line:KLM-1	10438-106E6	111.55	7.95	0.51	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	54.16	3.37	0.24	0.24	0.00
ductus deferens, adult	10196-103E7	104.15	6.48	3.99	1.99	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	106.58	11.52	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	111.08	2.21	5.15	2.94	1.47
dura mater, adult, donor1	10041-101F5	91.42	7.60	0.91	0.33	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	463.69	17.99	4.66	1.55	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	81.25	4.44	0.72	0.72	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	122.09	6.17	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	33.30	1.51	0.30	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	94.48	2.16	0.62	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	119.53	5.25	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	47.60	5.70	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	70.32	2.17	1.99	1.27	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	55.96	1.45	2.73	1.29	0.96
epidermoid carcinoma cell line:A431	10426-106D3	93.15	4.89	0.67	0.11	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	88.43	3.41	1.32	0.22	0.33
epididymis, adult	10197-103E8	74.93	5.44	1.26	0.84	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	60.50	2.66	2.31	1.42	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.90	0.79	0.39	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	82.95	2.10	3.54	1.97	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	142.12	3.54	4.13	2.56	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	76.52	1.68	1.90	0.90	0.78
esophagus, adult, pool1	10015-101C6	79.21	3.61	1.06	0.21	0.53
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	143.27	4.38	0.75	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	147.29	14.49	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	147.29	8.42	6.31	0.00	0.00
eye - muscle medial, donor2	10299-104H2	162.22	10.42	4.46	1.49	0.00
eye - muscle superior, donor2	10297-104G9	157.07	13.76	4.59	3.44	2.29
eye - vitreous humor, donor1	10268-104D7	155.94	20.40	0.00	2.91	0.00
eye, fetal, donor1	10054-101G9	82.63	7.63	2.80	1.53	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	41.93	1.92	1.28	0.38	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	82.38	5.70	2.14	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	166.54	6.66	1.60	0.47	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	125.20	6.31	4.50	2.10	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	83.39	1.46	0.46	0.64	0.09
gall bladder, adult	10198-103E9	54.08	4.83	1.69	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	99.85	7.52	1.07	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	96.36	5.98	0.37	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	59.35	5.07	2.32	2.75	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	51.84	1.93	0.97	0.77	0.19
gastric cancer cell line:AZ521	10549-107H9	86.24	2.95	0.98	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	95.18	8.24	0.92	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	78.59	4.57	3.20	2.06	1.14
giant cell carcinoma cell line:LU65	10487-107B1	44.98	0.69	0.11	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	214.00	6.44	1.26	1.40	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	97.27	5.49	2.24	2.24	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	58.05	1.06	0.53	0.11	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.75	1.12	0.98	0.14	0.56
glioblastoma cell line:T98G	10485-107A8	57.50	1.99	0.66	0.33	0.44
glioma cell line:GI-1	10413-106B8	86.11	2.05	0.59	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	206.28	9.48	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	211.14	7.81	3.91	3.42	1.95
globus pallidus, adult, donor10258	10367-105F7	91.74	9.58	2.74	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	67.15	3.73	0.53	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	12.24	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	87.43	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	57.92	2.56	1.60	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	109.73	8.72	1.38	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	107.91	8.69	2.74	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	110.14	6.44	3.86	1.29	0.00
hIPS, biol_rep1	14380-156B6	122.17	10.06	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	76.13	6.86	2.06	0.00	0.00
hIPS, biol_rep3	14382-156B8	111.45	3.31	3.31	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	83.90	6.32	2.30	1.72	0.86
heart - mitral valve, adult	10205-103F7	104.04	5.38	2.99	1.79	0.00
heart - pulmonic valve, adult	10206-103F8	107.47	5.49	3.40	1.05	1.05
heart - tricuspid valve, adult	10207-103F9	127.39	10.82	3.33	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	43.46	2.86	1.63	0.82	0.41
heart, adult, diseased, donor1	10051-101G6	26.83	4.68	0.43	0.43	0.85
heart, adult, pool1	10016-101C7	51.28	3.22	0.23	0.00	0.23
heart, fetal, pool1	10046-101G1	147.14	12.22	2.05	0.41	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	44.12	2.16	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	369.83	32.11	5.95	2.38	3.57
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	87.18	3.43	2.10	1.10	0.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	87.15	6.19	3.40	1.58	1.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	104.49	4.75	2.93	2.32	1.01
hepatoma cell line:Li-7	10484-107A7	77.74	0.33	0.67	0.44	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	67.13	6.93	2.21	0.80	0.30
hippocampus - adult, donor10196	10169-103B7	216.71	5.68	7.57	2.84	0.00
hippocampus, adult, donor10252	10153-102I9	166.55	5.71	4.49	2.04	0.82
hippocampus, adult, donor10258	10374-105G5	114.03	3.49	1.99	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	65.21	4.23	1.76	0.35	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	181.88	16.48	4.88	5.49	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	83.45	6.28	3.14	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	91.40	9.65	3.30	2.03	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	105.44	7.33	1.69	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	146.41	9.04	9.30	1.29	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	104.39	6.83	0.76	0.38	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	107.44	11.39	1.17	0.88	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	89.40	10.34	1.94	0.86	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	88.84	9.59	0.83	1.67	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	73.41	6.39	0.95	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	74.89	6.27	0.80	0.32	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	76.76	2.69	0.00	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	84.35	6.10	2.97	1.56	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	117.91	6.88	4.42	2.95	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	175.42	6.98	3.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	123.90	9.35	3.05	1.34	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	119.92	7.85	3.49	2.18	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	185.91	11.49	3.50	1.50	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	102.67	9.80	2.64	0.38	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	112.77	10.46	1.82	1.36	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	95.54	7.83	1.25	0.94	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	58.95	6.86	1.96	0.33	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	59.22	3.77	1.45	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	69.35	7.77	0.90	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	99.76	4.80	3.69	2.03	1.48
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	90.72	5.14	1.14	2.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	139.64	10.62	2.45	1.22	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	114.43	7.75	4.22	2.82	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	79.82	5.70	4.12	1.58	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	75.35	4.24	1.82	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	74.47	7.24	0.00	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	73.06	5.98	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	81.83	6.67	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	68.77	4.60	1.28	1.53	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	85.57	10.60	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	83.01	6.05	1.01	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	101.19	6.52	3.38	0.97	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	130.58	11.59	2.67	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	111.22	10.73	2.44	1.46	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	91.07	3.67	1.53	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	1031.28	45.55	3.25	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	128.41	8.27	1.65	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.89	10.95	1.09	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	92.64	8.32	1.45	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	82.21	6.05	2.49	1.07	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	100.24	1.19	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	133.94	7.72	1.22	0.41	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	77.05	4.85	1.89	0.54	0.00
immature langerhans cells, donor1	11904-125F5	170.47	14.77	1.21	0.73	0.24
immature langerhans cells, donor2	11905-125F6	130.70	5.54	0.79	0.79	1.58
insula, adult, pool1	10039-101F3	100.69	3.79	1.32	0.00	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	0.98	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	95.92	5.01	1.30	0.60	0.70
kidney, fetal, pool1	10045-101F9	93.51	6.58	0.99	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	117.31	3.41	0.14	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	36.63	1.38	0.69	0.55	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	64.04	0.92	0.37	0.37	0.18
left atrium, adult, donor1	10079-102A7	51.22	5.99	3.27	0.00	0.00
left ventricle, adult, donor1	10078-102A6	57.64	4.05	3.03	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	87.28	4.92	0.55	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	12.57	1.08	0.72	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	17.93	0.54	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	20.15	0.49	0.97	0.49	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	76.74	5.55	1.30	1.06	0.59
liposarcoma cell line:KMLS-1	10782-110G8	54.99	2.03	0.00	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	43.86	4.26	0.73	0.24	0.12
liver, adult, pool1	10018-101C9	55.42	1.46	0.81	0.16	0.00
liver, fetal, pool1	10086-102B5	24.46	3.76	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	174.84	11.52	4.23	1.46	0.87
locus coeruleus, adult, donor10252	10165-103B3	121.80	4.06	2.95	2.21	0.55
locus coeruleus, adult, donor10258	10375-105G6	57.56	4.23	0.85	0.56	0.28
locus coeruleus, newborn, donor10223	10362-105F2	161.10	9.67	3.36	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	38.34	1.38	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	127.54	3.45	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	92.01	7.25	1.71	0.40	0.00
lung, adult, pool1	10019-101D1	95.45	4.37	1.54	0.35	0.47
lung, fetal, donor1	10068-101I5	543.13	29.97	1.43	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	96.68	6.42	1.83	1.37	0.92
lymph node, adult, donor1	10077-102A5	44.02	4.73	1.42	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	56.55	1.53	0.44	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	105.65	4.38	0.60	0.45	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	248.90	7.65	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	133.20	2.22	0.44	0.89	0.00
mature adipocyte, donor2	12232-129F9	98.99	2.28	0.21	0.42	0.00
mature adipocyte, donor3	12233-129G1	127.07	1.90	0.24	0.24	0.71
mature adipocyte, donor4	12234-129G2	148.19	6.05	0.79	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	177.98	2.62	0.71	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	267.34	15.79	5.64	3.38	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	181.88	6.99	4.60	3.31	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	114.37	6.35	1.59	2.54	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	282.34	17.06	4.26	0.85	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	339.36	16.37	18.56	3.54	3.71
medial temporal gyrus, adult, donor10252	10156-103A3	184.00	6.37	6.15	2.55	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	134.84	9.63	9.63	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1665.02	186.60	229.66	71.77	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	104.45	7.90	0.36	0.72	0.36
medulla oblongata - adult, donor10196	10174-103C3	197.94	7.14	6.49	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	162.70	5.73	5.42	1.55	1.39
medulla oblongata, adult, pool1	10038-101F2	67.26	3.84	0.41	0.41	0.16
medulla oblongata, newborn, donor10223	10361-105F1	71.17	4.51	0.69	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	217.87	7.09	5.54	3.76	2.44
medulloblastoma cell line:ONS-76	10759-110E3	50.38	3.18	0.73	0.12	0.61
melanoma cell line:COLO 679	10514-107E1	52.32	2.44	0.14	0.14	0.43
melanoma cell line:G-361	10465-106H6	42.35	0.81	1.36	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	30.75	1.27	0.18	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	186.81	8.81	0.88	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	92.02	6.74	0.26	2.07	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	38.97	1.38	0.61	0.92	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.08	1.64	0.73	0.55	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	45.97	0.83	1.24	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.82	1.69	0.42	0.70	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.40	1.93	0.96	1.35	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.93	1.39	0.00	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	31.92	0.34	0.17	0.86	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	26.11	0.81	0.35	0.35	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	39.26	0.93	0.00	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	41.86	1.89	0.68	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	49.22	1.56	1.28	1.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	42.49	1.65	0.66	1.65	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	42.48	1.66	0.28	0.97	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	34.91	2.09	1.40	0.00	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	45.53	1.84	0.41	0.82	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	30.91	2.16	0.72	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	28.66	0.93	0.31	0.41	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	25.99	0.68	0.91	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	78.88	2.52	0.84	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	40.50	1.20	0.45	1.20	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	44.82	1.84	0.44	0.96	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	35.34	1.10	0.37	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.63	0.86	0.57	1.14	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.84	2.95	2.95	1.68	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	0.91	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	27.37	1.53	0.26	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	28.79	2.09	0.00	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	24.65	1.54	1.85	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	33.66	0.71	0.71	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.77	1.69	0.34	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.22	0.79	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.24	0.00	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.15	1.15	1.15	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.09	1.56	0.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.19	2.40	0.72	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	35.20	5.13	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	1.01	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	0.41	0.41	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.36	2.15	0.43	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	0.00	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	17.21	0.97	0.32	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	11.64	0.00	0.00	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	0.53	1.07	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	1.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.05	0.78	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	18.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.67	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	1.22	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	19.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.04	0.69	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.08	1.22	0.81	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	15.09	0.79	1.59	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	2.36	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.00	0.62	0.94	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	2.37	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	48.79	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	31.67	0.69	2.07	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.21	2.47	1.48	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	3.36	3.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	30.53	0.64	0.64	3.18	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	13.30	0.81	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	10.14	0.00	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	37.02	1.21	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	49.71	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	29.65	1.65	2.47	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	37.30	1.19	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	30.83	1.95	0.65	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	1.02	2.04	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	82.01	1.55	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	42.05	0.94	0.24	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	57.69	0.93	0.23	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	51.38	1.03	1.75	0.31	0.51
mesothelioma cell line:Mero-25	10850-111F4	46.53	1.13	1.13	0.45	0.91
mesothelioma cell line:Mero-41	10851-111F5	54.76	2.20	0.98	2.44	0.98
mesothelioma cell line:Mero-48a	10852-111F6	50.04	1.55	1.33	2.44	0.22
mesothelioma cell line:Mero-82	10853-111F7	63.07	3.94	3.94	2.37	1.58
mesothelioma cell line:Mero-83	10854-111F8	38.47	1.36	0.51	0.68	0.17
mesothelioma cell line:Mero-84	10855-111F9	18.96	2.53	1.01	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	47.00	2.69	1.45	1.04	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	45.88	1.16	2.15	1.33	0.99
mesothelioma cell line:NCI-H226	10846-111E9	32.40	1.27	0.90	1.81	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	42.88	2.05	1.37	1.88	0.17
mesothelioma cell line:NCI-H28	10845-111E8	45.29	2.29	0.51	2.04	1.27
mesothelioma cell line:No36	10857-111G2	45.34	0.98	0.65	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	43.62	1.08	0.81	0.81	0.54
migratory langerhans cells, donor1	11901-125F2	125.33	11.13	2.30	1.73	0.58
migratory langerhans cells, donor2	11902-125F3	52.75	4.27	0.24	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	75.38	5.20	0.54	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	51.26	1.31	2.61	1.31	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	29.04	1.27	0.42	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	72.10	2.76	0.69	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	46.24	2.47	0.00	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.25	3.70	0.74	0.55	0.55
myeloma cell line:PCM6	10474-106I6	63.25	3.16	1.98	0.59	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	99.43	10.65	1.52	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	49.82	1.18	1.37	0.78	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	28.75	1.23	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	31.99	1.18	0.07	0.07	0.07
nasal epithelial cells, donor2	12227-129F4	40.85	2.21	0.00	1.66	0.00
neuroblastoma cell line:CHP-134	10508-107D4	177.84	6.67	0.46	0.69	0.00
neuroblastoma cell line:NB-1	10539-107G8	204.86	6.36	1.50	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	66.64	2.74	1.90	1.69	1.05
neuroblastoma cell line:NH-12	10555-107I6	191.20	9.13	4.85	2.61	2.05
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	138.30	2.61	4.98	1.66	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	128.76	6.49	2.38	1.74	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	45.48	1.81	1.21	0.81	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	118.25	10.81	3.18	0.64	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	39.66	2.66	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	53.12	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	75.77	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	391.51	21.14	5.92	2.20	3.04
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	92.06	3.20	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	40.40	1.60	0.96	0.96	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	38.63	0.53	1.31	0.26	0.26
nucleus accumbens, adult, pool1	10037-101F1	105.08	4.78	0.84	0.28	0.56
occipital cortex - adult, donor10196	10172-103C1	385.29	10.30	8.24	8.24	0.00
occipital cortex, adult, donor10252	10163-103B1	215.23	5.37	4.83	1.07	1.61
occipital cortex, newborn, donor10223	10355-105E4	100.45	4.37	1.82	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	107.85	7.61	3.15	1.84	0.52
occipital lobe, fetal, donor1	10073-102A1	198.67	17.16	3.86	1.29	0.86
occipital pole, adult, pool1	10036-101E9	63.07	3.15	0.79	0.08	0.08
olfactory region, adult	10195-103E6	122.08	6.11	10.13	2.87	2.48
optic nerve, donor1	10277-104E7	136.07	20.01	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	120.74	2.62	2.05	0.46	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	80.37	4.12	0.96	0.41	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	64.00	4.74	2.71	1.69	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	61.45	4.04	1.50	2.08	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	34.10	1.76	0.00	0.88	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	175.65	6.54	0.00	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	83.34	1.70	0.85	0.00	0.42
ovary, adult, pool1	10020-101D2	85.78	6.11	0.70	0.17	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	65.08	5.13	1.10	0.73	0.92
pancreas, adult, donor1	10049-101G4	47.97	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	74.08	1.96	0.56	1.12	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	51.79	1.53	3.41	1.70	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	96.20	2.65	0.17	0.50	0.66
paracentral gyrus, adult, pool1	10035-101E8	100.67	5.49	1.10	0.46	0.37
parietal cortex, adult, donor10258	10373-105G4	102.03	6.61	2.20	3.67	0.00
parietal lobe - adult, donor10196	10171-103B9	199.38	13.17	9.40	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	202.66	6.56	7.41	2.85	1.43
parietal lobe, adult, pool1	10034-101E7	83.18	4.23	0.88	0.44	0.09
parietal lobe, fetal, donor1	10072-101I9	198.82	26.19	6.79	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	108.79	7.48	2.99	2.62	1.12
parotid gland, adult	10199-103F1	54.27	3.70	0.00	0.62	0.00
penis, adult	10200-103F2	92.38	3.22	4.30	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	269.79	4.09	6.88	3.72	2.42
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	56.24	3.06	1.60	1.31	1.31
pineal gland - adult, donor10196	10179-103C8	311.55	16.13	3.23	1.94	0.65
pineal gland, adult, donor10252	10160-103A7	354.74	13.03	6.51	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	94.06	6.27	1.25	0.00	1.88
pituitary gland - adult, donor10196	10180-103C9	263.07	10.12	6.07	3.04	3.04
pituitary gland, adult, donor10252	10162-103A9	426.32	15.11	6.78	1.56	0.52
pituitary gland, adult, donor10258	10378-105G9	126.84	10.21	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	94.28	3.98	0.97	0.32	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	133.49	4.63	1.99	1.85	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	67.39	2.18	0.47	0.31	0.16
pons, adult, pool1	10033-101E6	122.30	6.02	1.89	0.34	0.09
postcentral gyrus, adult, pool1	10032-101E5	55.71	3.84	0.70	0.61	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	44.06	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	68.90	4.81	1.89	1.02	0.58
prostate cancer cell line:PC-3	10439-106E7	113.98	4.72	4.17	2.00	0.91
prostate, adult, pool1	10022-101D4	98.94	7.80	0.54	0.45	0.36
putamen, adult, donor10196	10176-103C5	206.79	5.90	7.08	3.07	2.12
putamen, adult, donor10252	10152-102I8	96.08	1.96	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	95.07	5.46	2.19	2.19	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	80.46	5.07	4.83	2.90	1.45
putamen, newborn, donor10223	10365-105F5	285.62	5.25	3.75	2.25	0.00
rectal cancer cell line:TT1TKB	10469-106I1	74.48	3.78	1.16	0.00	0.29
rectum, fetal, donor1	10067-101I4	194.74	6.95	2.78	2.78	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	71.66	3.60	1.27	0.64	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	89.47	2.07	2.49	0.83	1.24
retina, adult, pool1	10030-101E3	69.98	3.98	0.89	0.30	0.20
retinoblastoma cell line:Y79	10475-106I7	148.87	6.75	3.90	2.08	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	76.84	5.29	2.58	0.74	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	251.96	25.59	1.97	1.41	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	100.79	9.09	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	52.44	1.94	1.29	0.65	0.81
salivary acinar cells, donor2	11772-123I8	55.63	3.03	1.79	1.51	0.41
salivary acinar cells, donor3	11773-123I9	105.27	11.25	1.32	1.32	0.00
salivary gland, adult, pool1	10093-102C3	38.89	1.14	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	62.90	2.19	1.26	0.25	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	59.36	2.47	1.53	0.47	0.00
seminal vesicle, adult	10201-103F3	111.63	5.29	3.70	2.12	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	73.36	3.40	1.46	1.70	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.52	1.26	1.01	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	50.18	3.01	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	72.94	2.42	1.61	1.48	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	96.49	2.76	0.88	0.11	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	69.54	2.58	0.52	0.65	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	117.04	17.73	4.26	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	87.31	6.12	0.12	0.60	0.12
skeletal muscle, fetal, donor1	10066-101I3	40.20	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	81.42	0.00	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	133.19	8.84	6.31	0.00	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	107.39	6.00	2.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	131.44	2.52	4.41	4.41	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	97.72	6.17	1.54	0.77	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	172.08	4.45	0.99	0.66	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	296.45	14.15	10.29	4.66	4.34
small cell lung carcinoma cell line:WA-hT	10562-108A4	135.54	8.93	2.18	1.31	0.87
small intestine, adult, pool1	10024-101D6	96.87	3.82	0.84	0.60	0.48
small intestine, fetal, donor1	10064-101I1	93.12	8.60	3.93	0.98	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	74.88	3.59	4.62	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	85.29	6.46	3.10	0.00	0.52
somatostatinoma cell line:QGP-1	10781-110G7	68.88	2.14	0.27	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	309.24	15.60	4.13	1.84	1.61
spinal cord, adult, donor10252	10159-103A6	229.47	5.52	5.13	2.76	0.39
spinal cord, adult, donor10258	10369-105F9	159.11	8.30	1.38	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	81.72	7.32	3.66	0.61	1.22
spinal cord, newborn, donor10223	10359-105E8	152.92	14.24	3.67	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	54.22	2.09	0.30	0.30	0.45
spleen, adult, pool1	10025-101D7	89.65	3.85	1.32	0.44	0.44
spleen, fetal, pool1	10044-101F8	82.87	6.36	0.64	0.40	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	80.43	6.21	2.07	0.72	0.41
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	60.76	2.09	0.57	0.00	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	62.55	2.80	1.75	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	39.87	2.74	0.78	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	95.34	5.52	1.35	0.68	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	44.48	1.69	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.96	0.00	0.42	0.42	0.42
stomach, fetal, donor1	10062-101H8	134.56	21.36	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	70.64	6.27	2.28	2.28	0.57
substantia nigra - adult, donor10196	10178-103C7	1356.85	108.55	542.74	108.55	108.55
substantia nigra, adult, donor10252	10158-103A5	153.70	6.44	4.78	2.28	1.87
substantia nigra, adult, donor10258	10371-105G2	105.00	3.10	4.14	1.55	0.00
substantia nigra, newborn, donor10223	10358-105E7	77.02	7.77	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	111.65	3.90	4.13	1.60	1.15
temporal lobe, adult, pool1	10031-101E4	50.69	3.05	0.85	0.00	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	128.21	13.53	6.41	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	90.98	6.59	2.64	1.32	1.76
tenocyte, donor1	11763-123H8	41.19	2.09	2.09	3.14	0.70
tenocyte, donor2	11765-123I1	33.57	1.91	2.29	0.76	0.00
tenocyte, donor3	11768-123I4	40.03	1.48	1.11	0.74	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	116.93	4.59	2.72	2.72	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	98.96	7.09	2.62	0.92	0.46
teratocarcinoma cell line:PA-1	10807-111A6	80.43	3.41	1.86	0.31	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	68.93	5.08	1.27	0.63	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	217.83	6.81	3.03	2.65	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	218.34	7.53	2.73	3.60	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	124.09	6.19	7.82	2.93	2.93
testis, adult, pool1	10026-101D8	92.34	4.40	1.50	0.21	0.21
testis, adult, pool2	10096-102C6	105.10	7.22	4.96	2.26	1.80
thalamus - adult, donor10196	10168-103B6	216.38	8.83	2.21	1.10	1.10
thalamus, adult, donor10252	10154-103A1	193.95	7.03	6.41	1.88	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	118.55	6.16	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	45.78	4.28	1.98	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	115.64	5.18	2.30	0.58	0.00
throat, adult	10209-103G2	89.88	6.74	1.50	1.75	2.00
throat, fetal, donor1	10061-101H7	108.48	11.58	3.05	1.83	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	76.11	9.54	1.99	0.60	0.60
thymus, adult, pool1	10027-101D9	110.75	7.26	1.29	0.50	0.60
thymus, fetal, pool1	10043-101F7	207.29	14.86	1.77	0.52	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	67.94	3.06	0.53	0.40	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	57.69	2.65	1.40	1.12	0.42
thyroid, adult, pool1	10028-101E1	96.30	5.51	0.84	0.56	0.37
thyroid, fetal, donor1	10060-101H6	117.07	13.18	4.22	2.64	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	153.98	12.32	3.08	3.08	3.08
tongue, adult	10203-103F5	77.91	3.72	2.56	2.56	0.47
tongue, fetal, donor1	10059-101H5	132.02	11.82	5.12	3.15	0.39
tonsil, adult, pool1	10047-101G2	75.83	6.21	0.50	0.10	0.00
trachea, adult, pool1	10029-101E2	92.27	4.74	0.49	0.41	0.16
trachea, fetal, donor1	10058-101H4	79.25	11.16	4.62	0.77	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	43.93	1.06	1.06	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	120.67	7.60	0.91	0.51	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	97.77	4.07	2.51	0.63	0.16
tridermal teratoma cell line:HGRT	10694-109G1	152.20	9.51	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	45.29	0.76	0.68	0.68	0.76
umbilical cord, fetal, donor1	10057-101H3	56.34	2.09	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	104.94	8.19	1.02	0.34	0.00
uterus, fetal, donor1	10055-101H1	105.97	10.75	3.58	2.05	0.00
vagina, adult	10204-103F6	121.49	5.17	0.00	0.00	0.00
vein, adult	10191-103E2	68.39	5.26	0.88	1.32	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	41.66	1.34	1.07	1.07	0.80